YU43985B - Process for micro-encapsulation of bikampicillin acid salts - Google Patents

Process for micro-encapsulation of bikampicillin acid salts

Info

Publication number
YU43985B
YU43985B YU2017/81A YU201781A YU43985B YU 43985 B YU43985 B YU 43985B YU 2017/81 A YU2017/81 A YU 2017/81A YU 201781 A YU201781 A YU 201781A YU 43985 B YU43985 B YU 43985B
Authority
YU
Yugoslavia
Prior art keywords
bikampicillin
encapsulation
micro
acid salts
salts
Prior art date
Application number
YU2017/81A
Other languages
English (en)
Other versions
YU201781A (en
Inventor
M L Beatty
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU201781A publication Critical patent/YU201781A/xx
Publication of YU43985B publication Critical patent/YU43985B/xx
Priority to BA970157A priority Critical patent/BA97157B1/bs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
YU2017/81A 1980-08-22 1981-08-20 Process for micro-encapsulation of bikampicillin acid salts YU43985B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BA970157A BA97157B1 (bs) 1980-08-22 1997-04-18 Postupak za dobivanje praha koji se rekonstruira sa vodom da bi dao suspenziju mikrokapsula adicione soli bakampicilina sa kiselinom

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/180,537 US4321253A (en) 1980-08-22 1980-08-22 Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration

Publications (2)

Publication Number Publication Date
YU201781A YU201781A (en) 1984-04-30
YU43985B true YU43985B (en) 1990-02-28

Family

ID=22660812

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2017/81A YU43985B (en) 1980-08-22 1981-08-20 Process for micro-encapsulation of bikampicillin acid salts

Country Status (41)

Country Link
US (1) US4321253A (fr)
JP (1) JPS5775986A (fr)
KR (1) KR860000513B1 (fr)
AR (1) AR227201A1 (fr)
AT (1) AT370994B (fr)
AU (1) AU529965B2 (fr)
BE (1) BE890028A (fr)
BG (1) BG42000A3 (fr)
CA (1) CA1137414A (fr)
CH (1) CH650674A5 (fr)
CS (1) CS225845B2 (fr)
DD (1) DD201644A5 (fr)
DE (1) DE3132614C2 (fr)
DK (1) DK158971C (fr)
DZ (1) DZ315A1 (fr)
ES (1) ES504905A0 (fr)
FI (1) FI72647C (fr)
FR (1) FR2488798A1 (fr)
GB (1) GB2082539B (fr)
GR (1) GR74983B (fr)
HK (1) HK43786A (fr)
HU (1) HU188679B (fr)
IE (1) IE51506B1 (fr)
IL (1) IL63617A (fr)
IN (1) IN156538B (fr)
IT (1) IT1138161B (fr)
KE (1) KE3626A (fr)
LU (1) LU83572A1 (fr)
MX (1) MX5731A (fr)
MY (1) MY8600597A (fr)
NL (1) NL191978C (fr)
NO (1) NO154821C (fr)
NZ (1) NZ198106A (fr)
PH (1) PH17125A (fr)
PL (1) PL232141A1 (fr)
PT (1) PT73555B (fr)
RO (1) RO82679B (fr)
SE (1) SE448819B (fr)
SU (1) SU1364226A3 (fr)
YU (1) YU43985B (fr)
ZA (1) ZA815793B (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2950977A1 (de) * 1978-12-22 1980-07-10 Donald E Panoz Neue galenische zubereitungsform fuer die orale verabreichung von medikamenten mit programmierter besetzung, sowie verfahren zu ihrer herstellung
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
EP0111560A4 (fr) * 1982-06-14 1987-02-03 Key Pharma Aspirine a liberation entretenue.
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
EP0113373B1 (fr) * 1982-07-09 1991-08-28 Key Pharmaceuticals, Inc. Forme de dosage de quinidine a liberation entretenue
AU569277B2 (en) * 1983-03-03 1988-01-28 Dow Chemical Company, The Aqueuos dispersion of water-insoluble organophilic cellulose ether for sustained release of active agents
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
SE8405611D0 (sv) * 1984-11-09 1984-11-09 Astra Laekemedel Ab Process for stabilization of bacampicillin hydrochloride
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
CA2134467A1 (fr) * 1992-04-30 1993-11-11 Donald Johnson Cephalosporine hydratee stable en poudre seche, utilisee dans une formulation d'une suspension orale
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
US6270804B1 (en) * 1998-04-03 2001-08-07 Biovail Technologies Ltd. Sachet formulations
IN191482B (fr) * 1999-03-19 2003-12-06 Ranbaxy Lab Ltd
JP4711478B2 (ja) * 1999-08-13 2011-06-29 旭化成ケミカルズ株式会社 味がマスクされた薬物
US20050037086A1 (en) * 1999-11-19 2005-02-17 Zycos Inc., A Delaware Corporation Continuous-flow method for preparing microparticles
AU784340B2 (en) 1999-12-23 2006-03-16 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
EP1118333A1 (fr) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions avec une biodisponibilité orale augmentée
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
DE60128215T2 (de) 2000-04-20 2008-01-10 Novartis Ag Beschichtungszusammensetzung zur geschmacksmaskierung
EP1292285A4 (fr) * 2000-06-02 2009-07-22 Eisai Corp North America Systemes de distribution d'agents bioactifs
FR2822834B1 (fr) * 2001-04-02 2005-02-25 Flamel Tech Sa Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
WO2002096392A1 (fr) * 2001-05-31 2002-12-05 Cima Labs Inc. Masquage du gout de medicaments hautement hydrosolubles
KR20030015655A (ko) * 2001-08-17 2003-02-25 한미약품공업 주식회사 항암제의 경구흡수율을 증가시키는 인단계 화합물의결정성 산부가염, 이의 제조방법 및 이를 함유하는 약학적조성물
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
ATE407674T1 (de) * 2002-04-09 2008-09-15 Flamel Tech Sa Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin
CN100553625C (zh) 2002-04-09 2009-10-28 弗拉梅技术公司 活性成分微囊的口服混悬液
FR2842735B1 (fr) * 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
FR2843117B1 (fr) * 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
FR2860516B1 (fr) * 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2862536B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
US7244765B2 (en) * 2004-06-25 2007-07-17 Cytokine Pharmasciences, Inc Guanylhydrazone salts, compositions, processes of making and methods of using
FR2885526B1 (fr) * 2005-05-13 2007-07-27 Flamel Technologies Sa Medicament oral a base d'inhibiteur de pompe a protons
EP3363442A4 (fr) * 2015-10-13 2019-03-06 Techno Guard CO. LTD. Composition protectrice de la muqueuse gastro-intestinale

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549746A (en) * 1967-11-02 1970-12-22 Bristol Myers Co Antibiotic composition
US3873521A (en) * 1970-09-17 1975-03-25 Astra Laekemedel Ab Esters of {60 -amino penicillins
ZA718014B (en) 1970-12-23 1972-08-30 Beecham Group Ltd Pharmaceutical formulations
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
GB1455296A (en) * 1973-05-24 1976-11-10 Beecham Group Ltd Veterinary treatment
GB1479655A (en) 1974-03-08 1977-07-13 Beecham Group Ltd Antibiotic preparations
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
JPS5840529B2 (ja) * 1975-09-29 1983-09-06 明治製菓株式会社 ケイコウヨウセイザイノセイホウ
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
ZA793935B (en) * 1978-08-04 1980-07-30 Beecham Group Ltd Powders
JPS57105316A (en) * 1980-12-23 1982-06-30 Hitachi Cable Ltd Method of fitting heat-shrinkable tube

Also Published As

Publication number Publication date
IT8123587A0 (it) 1981-08-20
IT1138161B (it) 1986-09-17
HK43786A (en) 1986-06-20
NL191978B (nl) 1996-08-01
RO82679A (fr) 1984-05-23
KR860000513B1 (ko) 1986-05-02
PT73555B (en) 1983-07-14
DE3132614C2 (de) 1985-08-22
LU83572A1 (fr) 1982-04-14
PH17125A (en) 1984-06-01
DZ315A1 (fr) 2004-09-13
KR830005850A (ko) 1983-09-14
NL191978C (nl) 1996-12-03
CS225845B2 (en) 1984-02-13
SU1364226A3 (ru) 1987-12-30
NO154821C (no) 1987-01-07
ZA815793B (en) 1982-08-25
AT370994B (de) 1983-05-25
ES8303091A1 (es) 1983-02-01
IN156538B (fr) 1985-08-31
IE811911L (en) 1982-02-22
FI812574L (fi) 1982-02-23
FI72647C (fi) 1987-07-10
GB2082539A (en) 1982-03-10
YU201781A (en) 1984-04-30
DK158971C (da) 1991-01-07
FI72647B (fi) 1987-03-31
HU188679B (en) 1986-05-28
IE51506B1 (en) 1987-01-07
GR74983B (fr) 1984-07-12
MY8600597A (en) 1986-12-31
AR227201A1 (es) 1982-09-30
PL232141A1 (fr) 1982-03-15
NZ198106A (en) 1983-12-16
AU7441681A (en) 1982-04-01
PT73555A (en) 1981-09-01
IL63617A (en) 1984-11-30
JPH0248525B2 (fr) 1990-10-25
FR2488798B1 (fr) 1985-01-11
KE3626A (en) 1986-05-16
RO82679B (ro) 1984-07-30
NO154821B (no) 1986-09-22
BE890028A (fr) 1982-02-22
AU529965B2 (en) 1983-06-30
DD201644A5 (de) 1983-08-03
IL63617A0 (en) 1981-11-30
GB2082539B (en) 1984-01-18
DE3132614A1 (de) 1982-05-19
BG42000A3 (en) 1987-09-15
CA1137414A (fr) 1982-12-14
DK158971B (da) 1990-08-13
MX5731A (es) 1993-11-01
NL8103902A (nl) 1982-03-16
JPS5775986A (en) 1982-05-12
US4321253A (en) 1982-03-23
ATA362781A (de) 1982-10-15
NO812827L (no) 1982-02-23
ES504905A0 (es) 1983-02-01
SE448819B (sv) 1987-03-23
DK372181A (da) 1982-02-23
SE8104974L (sv) 1982-02-23
CH650674A5 (fr) 1985-08-15
FR2488798A1 (fr) 1982-02-26

Similar Documents

Publication Publication Date Title
YU43985B (en) Process for micro-encapsulation of bikampicillin acid salts
PL243229A1 (en) Process for manufacturing derivatives of methylendiphosphonic acid
GB2072642B (en) Process for the preparation of sulfuric acid
YU133882A (en) Process for obtaining lysine salts of (1-benzyl-1h-imidazole3-yl)-oxy-acetic acid
PL238405A1 (en) Process for preparing novel derivatives of 2-aminocarboxylic acid
GB2082174B (en) Process for preparation of an optically active -mercaptoalkanoic acid
ZA815560B (en) Process for continuous preparation of diester of oxalic acid
DK153882A (da) Lodret valsemoelle (kollergang)
GB2067988B (en) Process for preparation of 3-alkoxy-4-hydroxyphenylacetic acids
DE3263557D1 (en) Process for the preparation of quinolinic acid
YU65784A (en) Process for making diniflumate morpholine-cetyl-esther of nifluminic acid
ZA813537B (en) Process for the preparation of diacetone-ketogulonic acid
DE3266003D1 (en) Process for preparation of 2-hydroxynaphthalene-3-carboxylic acid
YU96583A (en) Process for making derivatives of carbazine acid
DE3167735D1 (en) Process for the preparation of alkali metal salts of imidodisulphonic acid
BG42676A3 (en) Method for preparang derivatives of 6- aminoalkyl- penicillanic acid
YU45557B (en) Process for obtaining esther-sulphone-2-beta-chlormethyl-2-alpha-methylpenem-3-alpha of carboxylic acid
DE3360664D1 (en) Novel method for determination of 5-aminosalicylic acid
PL238418A1 (en) Process for preparing esters of vincaminic acid
DE3163621D1 (en) Process for the preparation of compounds of 2-aryloxy-2-halogen-propionic acid
GB2084146B (en) Process for preparing 4-aminomethyl-benzoic acid
DE3160219D1 (en) Process for treating an aqueous alcaline solution of anthraquinone-disulfonic acid salts
JPS56140968A (en) Manufacture of carbamoylsulfonic acid derivative salt
DE3162937D1 (en) Method of preparing diacetoketogulonic acid
YU135081A (en) Process for producing indolacetic acid derivatives